Skip to main content

Table 1 Description of the included studies

From: Systematic review and meta-analysis of propofol versus barbiturates for controlling refractory status epilepticus

Authors

Year

Cases (N)

Age (Years)

Gender (Male/female) (N)

APACHE II

All

Propofol

Barbiturates

Propofol

Barbiturates

Propofol

Barbiturates

Propofol

Barbiturates

van Gestel JP [14]

2005

42

22

20

Xiuquan F [12]

2005

18

9

9

45.2

46.3

4

5

6

3

26.5

23.9

Zengming W [11]

2011

14

7

7

41.2

43.3

3

4

5

2

23.5

22.9

Rossetti AO [15]

2011

23

14

9

57 (26–87)

64 (16–78)

7

7

3

6

Xiang C [13]

2016

18

9

9

45.2 ± 2.35

45.0 ± 2.39

6

3

7

2

24.1

24

Chunfen Z [17]

2017

90

45

45

26.3 ± 2.5

26.6 ± 2.6

23

22

24

21

Linzhi C [16]

2017

56

28

28

40.86 ± 2.89

41.35 ± 3.15

15

13

18

10

  1. N, cases, APACHE II, Acute Physiology and Chronic Health Evaluation II